Blackthorn Therapeutics' Series A - II Round

Blackthorn Therapeutics raised a round of funding on January 05, 2017.

Blackthorn Therapeutics is developing targeted medicines for neurodevelopmental disorders. BlackThorn leverages its INFORM platform, which supports the discovery and development of targeted treatments…

Articles about Blackthorn Therapeutics' Series A - II Round: